Boston Angel Investors →
CEO and Founder, Techstars
Senior health advisor for Esri
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder and CEO, Lighter Capital
Founder, The Haul Company
Executive Partner, Sofinnova Ventures
December 2, 2015 ·
December 10, 2015 ·
Acetylon is developing targeted HDAC inhibitor drugs.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2015, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.